Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin

Archives of Biochemistry and Biophysics

Volumn 646, Issue , 2018, Pages 31-37

  Huang, Yiyuan ^a   Cao, Shijie ^a   Zhang, Qiang ^a   Zhang, Hongyang ^a   Fan, Yuqi ^a   Qiu, Feng ^a   Kang, Ning ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti inflammatory; Anticancer; Antioxidant; Cardiovascular protective; Curcumin; Hexahydrocurcumin (HHC)

Indexed keywords

ANTHELMINTIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARDIOVASCULAR AGENT; CURCUMIN; DRUG METABOLITE; HEXAHYDROCURCUMIN; PROTECTIVE AGENT; UNCLASSIFIED DRUG; CARDIOTONIC AGENT;

ANTHELMINTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; DRUG MECHANISM; HEART PROTECTION; HUMAN; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; TUMOR CELL LINE;

ANIMALS; ANTHELMINTICS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CARDIOTONIC AGENTS; CELL LINE, TUMOR; CURCUMIN; HUMANS;

EID: 85049505786     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2018.03.030     Document Type: Review

References (111)

1. Newman, D.J., Cragg, G.M., Snader, K.M., Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66 (2003), 1022–1037.
2. Pandit, S., Kim, H.J., Kim, J.E., Jeon, J.G., Separation of an effective fraction from turmeric against Streptococcus mutans biofilms by the comparison of curcuminoid content and anti-acidogenic activity. Food Chem., 126, 2011, 1565.
3. Paramasivam, M., Poi, R., Banerjee, H., Bandyopadhyay, A., High-performance thin layer chromatographic method for quantitative determination of curcuminoids in Curcuma longa germplasm. Food Chem. 113 (2009), 640–644.
4. Ammon, H.P., Wahl, M.A., Pharmacology of Curcuma longa. Planta Med., 57, 1991, 1.
5. Chaturvedi, T.P., Uses of turmeric in dentistry: an update. Indian J. Dent. Res. 20 (2009), 107–109.
6. ® in mouse sera and organs with liquid chromatography tandem mass spectrometry. J. Pharmaceut. Biomed. Anal. 88 (2014), 117–122.
7. Jayakumar, S., Patwardhan, R.S., Pal, D., Sharma, D., Sandur, S.K., Dimethoxycurcumin, a metabolically stable analogue of curcumin enhances the radiosensitivity of cancer cells: possible involvement of ROS and thioredoxin reductase. Biochem. Biophys. Res. Commun. 478 (2016), 446–454.
8. Kalpravidh, R.W., Siritanaratkul, N., Insain, P., Charoensakdi, R., Panichkul, N., Hatairaktham, S., Srichairatanakool, S., Phisalaphong, C., Rachmilewitz, E., Fucharoen, S., Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids. Clin. Biochem. 43 (2010), 424–429.
9. Lin, R.J., Chen, C.Y., Lu, C.M., Ma, Y.H., Chung, L.Y., Wang, J.J., Lee, J.D., Yen, C.M., Anthelmintic constituents from ginger (Zingiber officinale) against Hymenolepis nana. Acta Trop. 140 (2014), 50–60.
10. Kunnumakkara, A.B., Anand, P., Aggarwal, B.B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Canc. Lett. 269 (2015), 199–225.
11. Panahi, Y., Saadat, A., Beiraghdar, F., Jalalian, H.R., Sahebkar, A., Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: a randomized double-blind placebo-controlled trial. J. Funct. Foods 6 (2014), 615–622.
12. Peret-Almeida, L., Alves, A.P.F.C.J., Dufosse, L., Gloria, M., Separation and determination of the physico-chemical characteristics of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Res. Int. 38 (2005), 1039–1044.
13. Khan, M.A., El-Khatib, R., Rainsford, K.D., Whitehouse, M.W., Synthesis and anti-inflammatory properties of some aromatic and heterocyclic aromatic curcuminoids. Bioorg. Chem. 40 (2012), 30–38.
14. Tapal, A., Tiku, P.K., Complexation of curcumin with soy protein isolate and its implications on solubility and stability of curcumin. Food Chem. 130 (2012), 960–965.
15. Lin, J.K., Molecular targets of curcumin. Adv. Exp. Med. Biol. 595 (2007), 227–243.
16. Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A.B., Aggarwal, B.B., Curcumin and cancer: an “old-age” disease with an “age-old” solution. Canc. Lett. 267 (2008), 133–164.
17. Goel, A., Kunnumakkara, A.B., Aggarwal, B.B., Curcumin as “Curecumin”: from kitchen to clinic. Biochem. Pharmacol., 75, 2008, 787.
18. Zhou, H., Beevers, C.S., Huang, S., Targets of curcumin. Curr. Drug Targets 12 (2011), 332–347.
19. B.B. Aggarwal, C. Sundaram, C.A. Mosley, D.C. Liotta, V.P. Menon, A.R. Sudheer, S. Shishodia, T. Singh, Y.J. Surh, K.S. Chun, The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, Springer US2007.
20. Wilken, R., Veena, M.S., Wang, M.B., Srivatsan, E.S., Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Canc., 10, 2011, 12.
21. Lao, C.D., Iv, M.T.R., Normolle, D., Heath, D.D., Murray, S.I., Bailey, J.M., Boggs, M.E., Crowell, J., Rock, C.L., Brenner, D.E., Dose escalation of a curcuminoid formulation. BMC Compl. Alternative Med., 6, 2006, 10.
22. Aggarwal, B.B., Sung, B.Y., Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci., 30, 2009, 85.
23. Asai, A., Miyazawa, T., Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. 67 (2000), 2785–2793.
24. Ireson, C.R., Jones, D.J., Orr, S., Coughtrie, M.W., Boocock, D.J., Williams, M.L., Farmer, P.B., Steward, W.P., Gescher, A.J., Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Canc. Epidemiol. Biomarkers Prev.: Publ. Am. Assoc. Cancer Res., Cospons. Am. Soc. Prev. Oncol., 11, 2002, 105.
25. Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (2007), 807–818.
26. Sharma, R.A., Steward, W.P., Gescher, A.J., Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol., 595, 2007, 453.
27. Shen, L., Ji, H.F., The pharmacology of curcumin: is it the degradation products?. Trends Mol. Med. 18 (2012), 138–144.
28. Manfred, M., Erika, P., Schulz, S.I., Dempe, J.S., Curcumin uptake and metabolism. Biofactors 39 (2013), 14–20.
29. Garcea, G., Berry, D.P., Jones, D.J., Singh, R., Dennison, A.R., Farmer, P.B., Sharma, R.A., Steward, W.P., Gescher, A.J., Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol. Biomark. Prev.: Publ. Am. Assoc. Cancer Res., Cospons. Am. Soc. Prev. Oncol., 14, 2005, 120.
30. Sharma, R.A., Euden, S.A., Platton, S.L., Cooke, D.N., Shafayat, A., Hewitt, H.R., Marczylo, T.H., Morgan, B., Hemingway, D., Plummer, S.M., Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. Off. J. Am. Ass. Cancer Res., 10, 2004, 6847.
31. Pan, M.H., Lin-Shiau, S.Y., Lin, J.K., Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem. Pharmacol. 60 (2000), 1665–1676.
32. Ireson, C., Orr, S., Jones, D.J.L., Verschoyle, R., Lim, C.K., Luo, J.L., Howells, L., Plummer, S., Jukes, R., Williams, M., Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Canc. Res., 61, 2001, 1058.
33. Sandur, S.K., Pandey, M.K., Sung, B., Ahn, K.S., Murakami, A., Sethi, G., Limtrakul, P., Badmaev, V., Aggarwal, B.B., Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis, 28, 2007, 1765.
34. Bo, W., Blennow, G., A study on the fate of curcumin in the rat. Basic Clin. Pharmacol. Toxicol. 43 (1978), 86–92.
35. Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., Srinivas, P.S.S.R., Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med., 64, 1998, 353.
36. Holder, G.M., Plummer, J.L., Ryan, A.J., The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 8 (1978), 761–768.
37. Pan, M.H., Huang, T.M., Lin, J.K., Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabol. Dispos. Biol. Fate Chem., 27, 1999, 486.
38. Anand, P., Thomas, S., Sundaram, Ab.C., Harikumar, K., Sung, B., Tharakan, S., Misra, K., Priyadarsini, I., Rajasekharan, K., Aggarwal, B., Biological activities of curcumin and its analogues (Congeners) made by man and mother nature. Biochem. Pharmacol. 76 (2008), 1590–1611.
39. Dempe, J.S., Scheerle, R.K., Pfeiffer, E., Metzler, M., Metabolism and permeability of curcumin in cultured Caco-2 cells. Mol. Nutr. Food Res., 57, 2013, 1543.
40. Somparn, P., Phisalaphong, C., Nakornchai, S., Unchern, S., Morales, N.P., Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol. Pharmaceut. Bull. 30 (2007), 74–78.
41. Deters, M., Knochenwefel, H., Lindhorst, D., Koal, T., Meyer, H.H., Hänsel, W., Resch, K., Kaever, V., Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities. Pharmaceut. Res. 25 (2008), 1822–1827.
42. Khanitta, Srimuangwong, ChainarongTocharus, Pornphrom, Yoysungnoen, Chintana, Apichart, Suksamrarn, Jiraporn, Tocharus, Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. World J. Gastroenterol., 18, 2012, 2383.
43. Lee, S.L., Huang, W.W., Lee, S.S., Chen, C.H., Preparation and anti-inflammatory activities of diarylheptanoid and diarylheptylamine analogs. Bioorg. Med. Chem., 13, 2005, 6175.
44. Dileep, K.V., Tintu, I., Sadasivan, C., Molecular docking studies of curcumin analogs with phospholipase A2. Interdiscipl. Sci. Comput. Life Sci., 3, 2011, 189.
45. Moohammadaree, A., Changtam, C., Wicha, P., Suksamrarn, A., Tocharus, J., Tocharus, C., Mechanisms of vasorelaxation induced by hexahydrocurcuminin isolated rat thoracic aorta. Phytother. Res. Ptr, 29, 2015, 1806.
46. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007), 44–84.
47. Karthikeyan, R., Manivasagam, T., Anantharaman, P., Balasubramanian, T., Somasundaram, S.T., Chemopreventive effect of Padina boergesenii extracts on ferric nitrilotriacetate (Fe-NTA)-induced oxidative damage in Wistar rats. J. Appl. Phycol. 23 (2011), 257–263.
48. Ferrari, C.K., Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology 5 (2004), 275–289.
49. Rahman, K., Studies on free radicals, antioxidants, and co-factors. Clin. Interv. Aging 2 (2007), 219–236.
50. Morales, N.P., Sirijaroonwong, S., Yamanont, P., Phisalaphong, C., Electron paramagnetic resonance study of the free radical scavenging capacity of curcumin and its demethoxy and hydrogenated derivatives. Biol. Pharmaceut. Bull., 38, 2015, 1478.
51. Li, F., Nitteranon, V., Tang, X., Liang, J., Zhang, G., Parkin, K.L., Hubd, Q., In vitro antioxidant and anti-inflammatory activities of 1-dehydro-[6]-gingerdione, 6-shogaol, 6-dehydroshogaol and hexahydrocurcumin. Food Chem., 135, 2012, 332.
52. Sugiyama, Y., Kawakishi, S., Osawa, T., Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol., 52, 1996, 519.
53. Peng, F., Tao, Q., Wu, X., Dou, H., Spencer, S., Mang, C., Xu, L., Sun, L., Zhao, Y., Li, H., Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger. Fitoterapia 83 (2012), 568–585.
54. Chen, W.F., Deng, S.L., Zhou, B., Yang, L., Liu, Z.L., Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H-atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups. Free Radical Biol. Med. 40 (2006), 526–535.
55. Feng, J.Y., Liu, Z.Q., Phenolic and enolic hydroxyl groups in curcumin: which plays the major role in scavenging radicals?. J. Agric. Food Chem. 57 (2009), 11041–11046.
56. Ferrero-Miliani, L., Nielsen, O.H., Andersen, P.S., Girardin, S.E., Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol., 147, 2007, 227.
57. Szabó C., Billiar, T.R., Novel roles of nitric oxide in hemorrhagic shock. Shock 12 (1999), 1–9.
58. Taylor, E.L., Megson, I.L., Haslett, C., Rossi, A.G., Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ. 10 (2003), 418–430.
59. Vila, L., Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med. Res. Rev. 24 (2004), 399–424.
60. Patel, R., Attur, M.G., Dave, M., Abramson, S.B., Amin, A.R., Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. J. Immunol. 162 (1999), 4191–4197.
61. Flower, R.J., The development of COX2 inhibitors. Nat. Rev. Drug Discov. 2 (2003), 179–191.
62. Shishodia, S., Sethi, G., Aggarwal, B.B., Curcumin: getting back to the roots. Ann. N. Y. Acad. Sci., 1056, 2005, 206.
63. Hanai, H., Sugimoto, K., Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr. Pharmaceut. Des., 15, 2009.
64. Youngjoon, S., Youngjoon, S., Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. Internat. J. Pub. British Ind. Biol. Res. Ass. 40 (2002), 1091–1097.
65. Gao, X., Xu, Y.X., Janakiraman, N., Chapman, R.A., Gautam∗ S.C., Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol., 62, 2001, 1299.
66. Li, J., Liu, Y., Wei, J.Q., Wang, K., Chen, L.X., Yao, X.S., Qiu, F., Isolation and identification of phase 1 metabolites of curcuminoids in rats. Planta Med. 78 (2012), 1351–1356.
67. Zhao, F., Gong, Y., Hu, Y., Lu, M., Wang, J., Dong, J., Chen, D., Chen, L., Fu, F., Qiu, F., Curcumin and its major metabolites inhibit the inflammatory response induced by lipopolysaccharide: translocation of nuclear factor-κB as potential target. Mol. Med. Rep., 11, 2015, 3087.
68. Zhao, F., Gao, Z., Jiao, W., Chen, L., Chen, L., Yao, X., In vitro anti-inflammatory effects of beta-carboline alkaloids, isolated from Picrasma quassioides, through inhibition of the iNOS pathway. Planta Med. 78 (2012), 1906–1911.
69. D.J. Hanahan, Handbook of Lipid Research, Plenum1978.
70. Verheij, H.M., Volwerk, J.J., Jansen, E.H.J.M., Puyk, W.C., Dijkstra, B.W., Drenth, J., Haas, G.H.D., Methylation of histidine-48 in pancreatic phospholipase A2. role of histidine and calcium ion in the catalytic mechanism. Biochemistry, 19, 1980, 743.
71. Singh, R.K., Singh, N., Jabeen, T., Sharma, S., Dey, S., Singh, T.P., Crystal structure of the complex of group I PLA2 with a group II-specific peptide Leu-Ala-Ile-Tyr-Ser (LAIYS) at 2.6 Å resolution. J. Drug Target. 13 (2005), 367–374.
72. Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S., Ko, J.Y., Lin, J.T., Lin, B.R., Mingshiang, W., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001), 2895–2900.
73. Hatcher, H., Planalp, R., Cho, J., Torti, F.M., Torti, S.V., Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. Cmls, 65, 2008, 1631.
74. Shehzad, A., Wahid, F., Lee, Y.S., Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv Der Pharmazie, 343, 2010, 489.
75. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell, 144, 2011, 646.
76. Gupta, S.C., Patchva, S., Aggarwal, B.B., Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J., 15, 2013, 195.
77. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., Dubois, R.N., Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998), 705–716.
78. Williams, C.S., Tsujii, M., Reese, J., Dey, S.K., Dubois, R.N., Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 105 (2000), 1589–1594.
79. Harris, R.E., Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Sub-cell. Biochem., 42, 2007, 93.
80. Arico, S., Pattingre, S., Bauvy, C., Gane, P., Barbat, A., Codogno, P., Ogier-Denis, E., Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J. Biol. Chem., 277, 2002 27613.
81. Elder, D.J.E., Halton, D.E., Playle, L.C., Paraskeva, C., The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Int. J. Canc. 99 (2002), 323–327.
82. Sun, Y., Tang, X.M., Half, E., Kuo, M.T., Sinicrope, F.A., Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Canc. Res., 62, 2002, 6323.
83. Plummer, S.M., Holloway, K.A., Manson, M.M., Munks, R.J., Kaptein, A., Farrow, S., Howells, L., Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene, 18, 1999, 6013.
84. Srimuangwong, K., Tocharus, C., Tocharus, J., Suksamrarn, A., Chintana, P.Y., Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats. World J. Gastroenterol. 18 (2012), 6951–6959.
85. Chen, C.Y., Yang, W.L., Kuo, S.Y., Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells. Nat. Prod. Commun., 6, 2011, 1671.
86. Santulli, G., Angiogenesis: Insights from a Systematic Overview. 2013.
87. Chang, J.H., Gabison, E.E., Kato, T., Azar, D.T., Corneal neovascularization. Ocul. Surf. 12 (2001), 242–249.
88. Adamis, A.P., Meklir, B., Joyce, N.C., In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells. Am. J. Pathol., 139, 1991, 961.
89. Kenyon, B.M., Voest, E.E., Chen, C.C., Flynn, E., Folkman, J., D'Amato, R.J., A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37 (1996), 1625–1632.
90. Kuo, C.N., Chen, C.H., Chen, S.N., Huang, J.C., Lai, L.J., Lai, C.H., Hung, C.H., Lee, C.H., Chen, C.Y., Anti-angiogenic effect of hexahydrocurcumin in rat corneal neovascularization. Int. Ophthalmol., 2017, 1–10.
91. Kléber, A.G., Rudy, Y., Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol. Rev., 84, 2004, 431.
92. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., Das, S.R., Ferranti, S.D., Després, J.P., Fullerton, H.J., Heart disease and stroke statistics—2016 Update. Circulation, 133, 2016 CIR.0000000000000350.
93. Wagner, D.D., Burger, P.C., Platelets in inflammation and thrombosis. Arterioscler. Thromb. Vasc. Biol., 23, 2003, 2131.
94. Collins, B., Hollidge, C., Antithrombotic drug market. market indicators. Nat. Rev. Drug Discov. 2 (2003), 11–12.
95. Palomo, I., Toro, C., Alarcón, M., The role of platelets in the pathophysiology of atherosclerosis (Review). Mol. Med. Rep., 1, 2008, 179.
96. Srivastava, K.C., Bordia, A., Verma, S.K., Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostagl. Leukot. Essent. Fat. Acids, 52, 1995, 223.
97. Shah, B.H., Nawaz, Z., Pertani, S.A., Roomi, A., Mahmood, H., Saeed, S.A., Gilani, A.H., Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca 2+ signaling. Biochem. Pharmacol. 58 (1999), 1167–1172.
98. Zhang, L., Gu, Z., Qin, Z., Liang, Z., Effect of curcumin on the adhesion of platelets to brain microvascular endothelial cells in vitro. Acta Pharmacol. Sin. 29 (2008), 800–807.
99. Dong, H.P., Yang, R.C., Chunag, I.C., Huang, L.J., Li, H.T., Chen, H.L., Chen, C.Y., Inhibitory effect of hexahydrocurcumin on human platelet aggregation. Nat. Prod. Commun. 7 (2012), 883–884.
100. Xu, P.H., Long, Y., Dai, F., Liu, Z.L., The relaxant effect of curcumin on porcine coronary arterial ring segments. Vasc. Pharmacol., 47, 2007, 25.
101. Livia, H., Andrea, J., Olga, U., Pavol, J., Andrea, Č., Pavel, B., Spice up the hypertension diet - curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension. Nutr. Metabol., 8, 2011, 72.
102. Sun, T., Liu, R., Cao, Y.X., Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms. Acta Pharmacol. Sin. 32 (2011), 1009–1018.
103. Farhangkhoee, H., Khan, Z.A., Mukherjee, S., Cukiernik, M., Barbin, Y.P., Karmazyn, M., Chakrabarti, S., Heme oxygenase in diabetes-induced oxidative stress in the heart. J. Mol. Cell. Cardiol. 35 (2003), 1439–1448.
104. Magalhães, L.G., Machado, C.B., Morais, E.R., Moreira, E.B., Soares, C.S., Da, S.S., Da, S.F.A., Rodrigues, V., In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol. Res., 104, 2009, 1197.
105. Shahiduzzaman, M., Dyachenko, V., Khalafalla, R.E., Desouky, A.Y., Daugschies, A., Effects of curcumin on Cryptosporidium parvum in vitro. Parasitol. Res. 105 (2009), 1155–1161.
106. Nagajyothi, F., Zhao, D., Weiss, L.M., Tanowitz, H.B., Curcumin treatment provides protection against Trypanosoma cruzi infection. Parasitol. Res. 110 (2012), 2491–2499.
107. Datta, A., Sukul, N.C., Antifilarial effect of Zingiber officinale on Dirofilaria immitis. J. Helminthol., 61, 1987, 268.
108. Merawin, L.T., Arifah, A.K., Sani, R.A., Somchit, M.N., Zuraini, A., Ganabadi, S., Zakaria, Z.A., Screening of microfilaricidal effects of plant extracts against Dirofilaria immitis. Res. Vet. Sci., 88, 2010, 142.
109. Shen, C.L., Hong, K.J., Kim, S.W., Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. J. Med. Food 8 (2005), 149–153.
110. Yao, H., Tong, J., Wang, Z., Zhang, Z.Q., Chen, J.X., [Effect of acupoint application therapy on expression of IL-4 and IFN-gamma in lung tissue of asthma rats]. Acupunct. Res., 32, 2007, 174.
111. Ahui, M.L.B., Champy, P., Ramadan, A., Van, L.P., Araujo, L., André K.B., Diem, S., Damotte, D., Kati-Coulibaly, S., Offoumou, M.A., Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation. Int. Immunopharm. 8 (2008), 1626–1632.